Press "Enter" to skip to content

FDA grants Jacobus Pharma approval for rare disease drug

Jacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder.

Original source:

Also Read:   Providence to sell 30 mn doses of PTX-Covid19-B to Biological E